Senior Director Health Economics Outcomes Research

Would you like to join an international team working to improve the future of healthcare? Do you want to enhance the lives of millions of people? Grifols is a global healthcare company that since 1909 has been working to improve the health and well-being of people around the world. We are leaders in plasma-derived medicines and transfusion medicine and develop, produce and market innovative medicines, solutions and services in more than 110 countries and regions.

Grifols is seeking a visionary and scientifically grounded leader for an industry-leading Global HEOR/RWE team.  The successful candidate will partner with cross‑functional stakeholders to ensure HEOR/RWE plans and deliverables are scientifically rigorous, decision‑relevant, and ready to support clinical studies, payer/HTA engagement, pricing, and reimbursement. With responsibility across a diverse therapeutic portfolio and modalities — including plasma-derived products and recombinant proteins — this role offers a rare opportunity to build future-ready Global HEOR/RWE capabilities, influence portfolio strategy, and lead a dynamic team to translate deep scientific insight into medicines that meaningfully improve patients’ lives.

Strategic & Scientific Leadership

• Define and own the global HEOR/RWE vision, strategy, and multi‑year evidence generation roadmap, ensuring alignment with pipeline, launch, and lifecycle priorities and integration of RWE into value demonstration, HTA engagement, and pricing and reimbursement decision‑making.
• Provide senior scientific leadership to cross‑functional teams and executive management, serving as a trusted advisor on program risk, opportunity, and strategic trade‑offs.
• Define the enterprise strategy for the use of RWE in regulatory, payer, and HTA contexts, serving as the senior HEOR/RWE partner to Regulatory Affairs and global health authorities.
• Lead integrated evidence planning with cross‑functional stakeholders to align research questions, endpoints, and study designs with payer/HTA requirements and value hypotheses.

HEOR/RWE Excellence

• Establish and govern Global HEOR/RWE standards, processes, and quality frameworks to ensure scientific rigor, consistency, compliance, and decision‑grade evidence across deliverables.
• Lead the design, execution, and interpretation of HEOR/RWE studies (e.g., comparative effectiveness, burden of illness, treatment patterns, PRO/COA, registries, claims/EHR analyses, and economic models), ensuring fit‑for‑purpose methods and clear decision recommendations.
• Ensure evidence is translated into access‑enabling deliverables (e.g., global value dossier/AMCP dossier content and support for HTA submissions), aligned to stakeholder needs across priority markets.
• Oversee the end‑to‑end HEOR/RWE portfolio (book of work), including prioritization, resourcing, budgets, timelines, performance metrics, and proactive risk management.
• Lead the publication and dissemination strategy for HEOR/RWE projects to strengthen scientific credibility and visibility in priority disease areas.
• Monitor evolving methodologies and policy trends across payers, HTA bodies, and RWE to inform standards, training, and evidence strategy updates.

Organizational Leadership & Capability Building

• Lead and develop a globally-distributed HEOR/RWE team (health economists, outcomes researchers, epidemiologists, statisticians/analysts, and scientific communications partners), including hiring, coaching, performance management, and succession planning.
• Build and scale operating capabilities (data strategy, analytics, vendor ecosystem, tools, and training) to support pipeline growth and lifecycle evidence needs.
• Ensure excellence in scientific quality, documentation, and compliance (e.g., protocol/SAP governance, data privacy, vendor oversight, and audit readiness) across HEOR/RWE activities.
• Drive continuous improvement of HEOR/RWE operations, including ways of working, tools, and training to increase speed and quality of delivery.

Cross‑Functional Collaboration

• Partner with key stakeholders (Clinical Development, Regulatory, Biostatistics, Medical Affairs, Pharmacovigilance, Commercial/Market Access, Legal, Finance, and Global Program Teams) to align evidence plans with development and access priorities.
• Foster a collaborative, matrix‑based culture that promotes transparency, scientific rigor, and shared ownership of outcomes.
• Represent HEOR/RWE in internal governance bodies and executive forums, communicating evidence strategy, insights, and implications for access and value positioning.
• Develop and maintain strategic external relationships (payers, HTA bodies, KOLs, scientific societies, and patient advocacy groups) to inform evidence standards and enhance value communication.

Core Deliverables

• Integrated HEOR/RWE evidence strategies and multi‑year roadmaps for priority assets.
• Study protocols and analysis plans (SAPs) for priority HEOR/RWE studies, with clear governance and quality standards.
• Access‑enabling value communication packages (e.g., global value dossier/AMCP dossier content; economic models; HTA submission support).
• Portfolio‑level HEOR/RWE operating plan (priorities, resourcing, budgets, timelines, and performance metrics).
• Scientific dissemination plan and outputs (publications, congress abstracts, and external collaborations).

What Success in This Role Looks Like

• An integrated HEOR/RWE evidence strategy is established early for priority assets and is demonstrably aligned to target product profiles, access needs, and lifecycle plans.
• High‑quality RWE and outcomes studies are designed and executed with appropriate methods, governance, and vendor oversight—delivering decision‑relevant insights on effectiveness, safety, burden of illness, treatment patterns, and unmet need.
• HEOR deliverables (e.g., economic models, global value dossier/AMCP dossier content, COA/PRO strategy) are market‑ready, internally aligned, and stand up to external scientific and payer/HTA scrutiny.
• The function becomes a trusted strategic partner to Global Program Teams, Regulatory, Medical Affairs, and Commercial—informing key trade‑offs (endpoints, comparators, populations, evidence gaps) to improve probability of technical and access success.
• Clear HEOR/RWE standards, quality frameworks, and operating rhythms are embedded across the portfolio (protocol review, analysis plans, documentation, compliance), with measurable improvements in speed, quality, and consistency of outputs.
• Effective payer/HTA engagement is enabled through well‑framed value hypotheses and evidence packages, supporting pricing and reimbursement objectives in priority markets.
• A visible scientific footprint is built through high‑impact publications, congress presence, and external collaborations that strengthen credibility of Grifols evidence generation in priority disease areas.
• A high‑performing HEOR/RWE organization is developed with clear roles, succession planning, training, and scalable capabilities (data strategy, analytics, vendor ecosystem) to support pipeline growth and lifecycle needs.

Skills/Qualifications/Education Requirements: (To perform this job successfully, an individual must be able to perform each essential duty satisfactorily. The requirements listed below are representative of the knowledge, skills, education, and/or ability required. Reasonable accommodations may be made to enable individuals with disabilities to perform the essential functions)

Education

• MD, MD/PhD, PhD, PharmD, or equivalent advanced scientific/medical degree

Experience

• Typically 15+ years of experience in HEOR/RWE within pharma, biotech, or medical devices
• Deep knowledge of outcomes research and RWE methodologies (study design, statistics, data sources, and implementation)
• Proven experience managing vendors, budgets, and building productive partnerships with internal stakeholders and external experts/KOLs
• Excellent communication skills, with the ability to translate complex analyses into clear recommendations for senior stakeholders
• Demonstrated leadership in matrixed environments, including the ability to direct work across functions to deliver shared objectives
• Experience across multiple therapeutic areas; experience in Neurology, Immunology, Hematology, Coagulation, and/or Critical Care is preferred
• Experience across multiple therapeutic areas and development modalities is strongly preferred

Leadership & Personal Attributes

• Credible, team-oriented HEOR/RWE leader with executive presence and a strategic mindset
• Collaborative, inclusive leader who inspires teams and encourages innovation
• Comfortable navigating complexity, ambiguity, and change
• Strong communicator with the ability to influence at senior and executive levels
• Hands‑on, pragmatic, and outcomes‑driven, aligned with Grifols’ culture and values

Depending on the area of assignment, directly related experience or a combination of directly related education and experience and/or competencies may be considered in place of the stated requirements.  Example:  If a job level requires a Bachelor’s degree plus 4 years of experience, an equivalency could include 8 years of experience, an Associate’s degree with 6 years of experience, or a Master’s degree with 2 years of experience.

Work is performed in an office environment with exposure to electrical office equipment. Frequently sits for 6-8 hours per day. Repetitive hand movement of both hands with the ability to make fast, simple, repeated movements of the fingers, hands, and wrists.   Occasionally walks and stands. Occasionally bends and twists neck.  Light to moderate lifting and carrying objects with a maximum lift of 25lbs. Frequently drives to site locations with occasional travel within the United States. Able to communicate information and ideas so others will understand; with the ability to listen to and understand information and ideas presented through spoken and written words and sentences.  Interacts with others, relates sensitive information to diverse groups. Must work with diverse groups to obtain consensus on issues.

#LI-CB1

Third Party Agency and Recruiter Notice:

Agencies that present a candidate to Grifols must have an active, nonexpired, Grifols Agency Master Services Agreement with the Grifols Talent Acquisition Department. Additionally, agencies may only submit candidates to positions that they have been engaged to work on by a Grifols Recruiter. All resumes must be sent to a Grifols Recruiter under these terms or they will be considered a Grifols candidate.

Grifols provides equal employment opportunities to applicants and employees without regard to race; color; sex; gender identity; sexual orientation; religious practices and observances; national origin; pregnancy, childbirth, or related medical conditions; status as a protected veteran or spouse/family member of a protected veteran; or disability.  We will consider for employment all qualified applicants in a manner consistent with the requirements of all applicable laws.

Location: NORTH AMERICA : USA : NC-RTP:USNC0001 - RTP NC-Headquarters 

Learn more about Grifols